-
Product Insights
Net Present Value Model: ORIC-944
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model ORIC-944 Drug Details ORIC-944 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ORIC-533
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ORIC-533 Drug Details ORIC-533 is under development for the treatment of relapsed or refractory...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ORIC-944
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ORIC-944 Drug Details ORIC-944 is under development for the treatment of metastatic hormone refractory (castration...
-
Product Insights
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Symptoms may include night sweats, fever and chills that come and go, itching, putting pressure on the windpipe (trachea) or other airways, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if cancer affects the brain. Treatment includes surgery,...
-
Product Insights
5′ Nucleotidase (Ecto 5′ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
5′-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5'nucleotides. The 5′ Nucleotidase drugs in development market research report provides an in-depth analysis of 5′ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) targeted pipeline therapeutics. The report provides comprehensive information on the 5′ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) targeted therapeutics, complete with analysis...
-
Sector Analysis
North America Peripheral Vascular Devices Market Outlook to 2025 – Arteriotomy Closure Devices, Carotid and Renal Artery Stents, Peripheral Embolic Protection
GlobalData’s “North America Peripheral Vascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Peripheral Vascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arteriotomy Closure Devices, Carotid and Renal Artery Stents, Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloon Catheters, PV Embolization Plugs & Coils and Renal Denervation Catheters. The North America Peripheral Vascular Devices Market report...
-
Sector Analysis
United States Peripheral Vascular Devices Market Outlook to 2025 – Aortic Stent Grafts, Arteriotomy Closure, Carotid and Renal Artery Stents, Inferior Vena Cava Filters (IVCF), Peripheral Embolic Protection, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloons Catheters, PTA Peripheral Drug Eluting Balloons (DEB) Catheters, Renal Denervation Catheters, Tip Location Devices and Vascular Grafts
GlobalData’s “United States Peripheral Vascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Peripheral Vascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arteriotomy Closure Devices, Carotid and Renal Artery Stents, Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloon Catheters, PV Embolization Plugs & Coils and Renal Denervation Catheters. The United States Peripheral Vascular Devices Market report...
-
Sector Analysis
United States Cardiovascular Devices Market Outlook to 2025 – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others
GlobalData’s “United States Cardiovascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Cardiovascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Clot Management Devices, Electrophysiology Devices, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The United States Cardiovascular Devices...